SCHEMBL4984735

SCHEMBL4984735

CC12CC3(C)CC(C)(C1)CC(CC(=O)Nc1ncnc4c1CCN(Cc1ccccc1)C4)(C2)C3

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BRS3 P32247 3/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
MKNK1 Q9BUB5 5/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 1/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
LIMK1 P53667 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4991840 0.91 BRS3 (0.37) BRS3KMT2AMEN1RXFP1PTPN2
SCHEMBL14272249 0.88 BRS3 (0.41) BRS3KMT2AMEN1RXFP1PTPN2
SCHEMBL14296826 0.87 BRS3 (0.36) BRS3KMT2AMEN1RXFP1PTPN2
SCHEMBL14300850 0.85 BRS3 (0.35) BRS3KMT2AMEN1RXFP1PTPN2
SCHEMBL4983637 0.85 P2RX7 (0.47) KMT2AMEN1ALDH1A1SMN1; SMN2LMNA
SCHEMBL4982834 0.84 KMT2A (0.44) BRS3KMT2AMEN1RXFP1PTPN2
SCHEMBL4989382 0.84 LMNA (0.38) KMT2AMEN1MKNK1KDM4EALDH1A1
SCHEMBL13532746 0.84 MEN1 (0.42) BRS3KMT2AMEN1RXFP1MKNK1
SCHEMBL5141408 0.82 P2RX7 (0.38) KMT2AMEN1RAB9AMAPTNPSR1
SCHEMBL4982656 0.81 P2RX7 (0.38) ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 BRS3 380/4885KMT2A 4614/4885MEN1 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.